|
- Cetuximab Uses, Side Effects Warnings - Drugs. com
Cetuximab: side effects, dosage, interactions, FAQs, reviews Used for: colorectal cancer, head and neck cancer, non small cell lung cancer, pancreatic cancer, and more
- Cetuximab - Wikipedia
Cetuximab, sold under the brand name Erbitux, is an epidermal growth factor receptor (EGFR) inhibitor medication used for the treatment of metastatic colorectal cancer and head and neck cancer [1]
- Cetuximab - NCI - National Cancer Institute
Cetuximab is approved to be used alone or with other drugs to treat: Colorectal cancer that has spread to other parts of the body It is used: In patients whose cancer has the EGFR protein and the wild-type KRAS gene It is used: With FOLFIRI combination chemotherapy as the first treatment
- Cetuximab - StatPearls - NCBI Bookshelf
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor with the following FDA-approved indications: colorectal cancer, metastatic, KRAS wild-type (without mutation), and head and neck cancer (squamous cell)
- Cetuximab (Erbitux): Uses Side Effects - Cleveland Clinic
Cetuximab is a medication that treats colorectal cancer This type of cancer develops from polyps (growths) in your colon’s inner lining Cetuximab can also treat head and neck cancer A healthcare provider will give you this infusion into your vein in a hospital or clinic What is this medication? CETUXIMAB (se TUX i mab) is a monoclonal antibody
- Cetuximab (Erbitux) | Cancer information | Cancer Research UK
Cetuximab is a type of targeted cancer drug It is a treatment for advanced bowel cancer and neck cancers Find out about how you have it, possible side effects and other important information
- Cetuximab - Chemocare
CETUXIMAB (se TUX i mab) treats head and neck cancer It may also be used to treat colorectal cancer It works by blocking a protein that causes cancer cells to grow and multiply This helps to slow or stop the spread of cancer cells It is a monoclonal antibody
|
|
|